BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 11704847)

  • 21. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.
    He LZ; Merghoub T; Pandolfi PP
    Oncogene; 1999 Sep; 18(38):5278-92. PubMed ID: 10498880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Characteristics and Clinical Significance of 12 Fusion Genes in Acute Promyelocytic Leukemia: A Systematic Review.
    Yan W; Zhang G
    Acta Haematol; 2016; 136(1):1-15. PubMed ID: 27089249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional regulation in acute promyelocytic leukemia.
    Lin RJ; Sternsdorf T; Tini M; Evans RM
    Oncogene; 2001 Oct; 20(49):7204-15. PubMed ID: 11704848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
    Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute promyelocytic leukemia: a novel PML/RARalpha fusion that generates a frameshift in the RARalpha transcript and ATRA resistance.
    Zayed A; Couban S; Hayne O; Sparavalo N; Shawwa A; Sadek I; Greer W
    Leuk Lymphoma; 2007 Mar; 48(3):489-96. PubMed ID: 17454588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute promyelocytic leukemia and variant fusion proteins: PLZF-RARα fusion protein at a glance.
    Hussain L; Maimaitiyiming Y; Islam K; Naranmandura H
    Semin Oncol; 2019 Apr; 46(2):133-144. PubMed ID: 31126665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent
    Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M
    Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
    Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
    Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interstitial insertion of RARα gene into PML gene in a patient with acute promyelocytic leukemia (APL) lacking the classic t(15;17).
    Goldschmidt N; Yehuda-Gafni O; Abeliovich D; Slyusarevsky E; Rund D
    Hematology; 2010 Oct; 15(5):332-7. PubMed ID: 20863428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
    Gu BW; Xiong H; Zhou Y; Chen B; Wang L; Dong S; Yu ZY; Lu LF; Zhong M; Yin HF; Zhu GF; Huang W; Ren SX; Gallagher RE; Waxman S; Chen GQ; Wang ZG; Chen Z; Fu G; Chen SJ
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7640-5. PubMed ID: 12032336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein.
    Dong S; Zhu J; Reid A; Strutt P; Guidez F; Zhong HJ; Wang ZY; Licht J; Waxman S; Chomienne C; Chen Z; Zelent A; Chen SJ
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3624-9. PubMed ID: 8622986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulsed-field gel electrophoresis analysis of retinoic acid receptor-alpha and promyelocytic leukemia rearrangements. Detection of the t(15;17) translocation in the diagnosis of acute promyelocytic leukemia.
    Xiao YH; Miller WH; Warrell RP; Dmitrovsky E; Zelenetz AD
    Am J Pathol; 1993 Nov; 143(5):1301-11. PubMed ID: 8238249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.
    Grimwade D; Gorman P; Duprez E; Howe K; Langabeer S; Oliver F; Walker H; Culligan D; Waters J; Pomfret M; Goldstone A; Burnett A; Freemont P; Sheer D; Solomon E
    Blood; 1997 Dec; 90(12):4876-85. PubMed ID: 9389704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
    Chen SJ; Chen LJ; Zhou GB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered nuclear cofactor switching in retinoic-resistant variants of the PML-RARα oncoprotein of acute promyelocytic leukemia.
    Farris M; Lague A; Manuelyan Z; Statnekov J; Francklyn C
    Proteins; 2012 Apr; 80(4):1095-109. PubMed ID: 22228505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Stat5-RARalpha fusion protein represses transcription and differentiation through interaction with a corepressor complex.
    Maurer AB; Wichmann C; Gross A; Kunkel H; Heinzel T; Ruthardt M; Groner B; Grez M
    Blood; 2002 Apr; 99(8):2647-52. PubMed ID: 11929749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
    Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
    Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region.
    Sakamoto K; Imamura T; Yano M; Yoshida H; Fujiki A; Hirashima Y; Hosoi H
    Blood Cancer J; 2014 Apr; 4(4):e205. PubMed ID: 24769646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.